Synokem Pharmaceuticals Limited, a active public limited company, was established on 18 August 1983 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U34239DL1983PLC016353. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹4.82 Cr.
Formerly known as Synokem Pharmaceuticals Private Limited. It upholds a compliant status. Employing 363 professional, Its leadership includes Gajanan Mohan Shenoy (Director), Vishal Gupta (Nominee Director), Abhinav Arora (Managing Director). Past directors included Sonam Bansal, Anmol Srivastava, Gajanan Mohan Shenoy. It holds ₹185.00 Cr open charges and ₹14.75 Cr settled loans. Its latest AGM occurred on 14 December 2024, with the balance sheet filed on 31 March 2024. It is based at 14/486 , Basement & Ground Floor, Outer Ring Road, Paschim Vihar, New Delhi, Delhi, 110087.
U34239DL1983PLC016353
016353
18 August 1983
₹6.00 Cr
₹4.82 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Synokem Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gajanan Mohan Shenoy | Director | 30 Mar 2024 | Current |
| Vishal Gupta | Nominee Director | 18 Jan 2023 | Current |
| Abhinav Arora | Managing Director | 01 Jul 2005 | Current |
| Thomas Baby | Director | 01 Jul 2019 | Current |
| Shubhangi Agarwal | Director | 01 Apr 2022 | Current |
| Dhiraj Poddar | Nominee Director | 24 Jul 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2022 | Past |
| Pramod Abcsdd | Director | 18 Jan 2023 | Past |
| Pramod Abcsdd | Additional Director | 07 Apr 2024 | Past |
| Pramod Abcsdd | Additional Director | 18 Jan 2023 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Director | 27 Dec 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Synokem Pharmaceuticals Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 12.18% decrease. The company also saw a slight decrease in profitability, with a 9.62% decrease in profit. The company's net worth Soared by an impressive increase of 16.16%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Synokem Pharmaceuticals had a promoter holding of 98.00% and a public holding of 2.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,850,000,000.00
₹147,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jul 2024 | Axis Bank Limited | ₹22.50 Cr | Open |
| 06 May 2024 | Others | ₹15.00 Cr | Open |
| 16 Jan 2024 | Others | ₹20.00 Cr | Open |
| 22 Sep 2023 | Others | ₹115.00 Cr | Open |
| 16 Feb 2009 | Others | ₹12.50 Cr | Open |
Explore comprehensive loan charge details -
Synokem Pharmaceuticals has a workforce of 363 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Synokem Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synokem Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others of Rs. 12.50 Cr registered on 16 Feb 2009 with Charge ID 10145202 was modified on 26 Aug 2025. was documented.
The activity A charge with Axis Bank Limited of Rs. 22.50 Cr registered on 31 Jul 2024 with Charge ID 100961273 was modified on 15 Apr 2025. was completed.
A charge with Others of Rs. 20.00 Cr registered on 16 Jan 2024 with Charge ID 100848505 was modified on 07 Mar 2025. was recorded as a recent event.
Synokem Pharmaceuticals Limited last Annual general meeting of members was held on 14 Dec 2024 as per latest MCA records. was recorded as a recent event.
The activity A charge with Axis Bank Limited amounted to Rs. 22.50 Cr with Charge ID 100961273 was registered on 31 Jul 2024. was completed.
Progress on Dhiraj Poddar was appointed as a Nominee Director was appointed as a Nominee Director on 24 Jul 2024 & has been associated with this company since 1 year 4 months . was documented.
The CIN of Synokem Pharmaceuticals Limited is U34239DL1983PLC016353.
Synokem Pharmaceuticals Limited is headquartered at 14/486 , Basement & Ground Floor, Outer Ring Road, Paschim Vihar, New Delhi, Delhi, 110087.
Synokem Pharmaceuticals Limited was incorporated on 18 August 1983.
The current directors of Synokem Pharmaceuticals Limited are
The primary industry of Synokem Pharmaceuticals Limited is Manufacturing.
Synokem Pharmaceuticals Limited is unlisted.
The authorized capital of Synokem Pharmaceuticals Limited is ₹6.00 Cr, and the paid-up capital is ₹4.82 Cr.
The compliance status of Synokem Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX